Table 2.
Changes in parameters related to CKD-MBD and atherosclerosis
| LC (n = 24) | CC (n = 26) | |||
|---|---|---|---|---|
| 0 M | 18 M | 0 M | 18 M | |
| cCa (mg/dL) | 8.5 ± 0.8 | 8.8 ± 0.8 | 8.4 ± 0.8 | 9.2 ± 0.6† |
| P (mg/dL) | 6.0 ± 1.3 | 5.5 ± 1.2 | 5.9 ± 1.5 | 5.1 ± 1.4 |
| iPTH (pg/mL) | 216.0 (128.5–531.8) | 155.0 (69.1–194.5)* | 281.0 (217.8–422.5) | 98.5 (38.0–192.8)† |
| iFGF23 (pg/mL) | 737.5 (456.8–1875.9) | 2430.5 (750.8–7560.8)* | 588.1 (264.5–1880.6) | 2630.4 (747.1–13,741.8)† |
| LDL-C (mg/dL) | 86.0 ± 37.2 | 84.4 ± 24.4 | 86.8 ± 30.6 | 73.6 ± 23.1† |
| PS | 6.7 (3.8–14.1) | 9.2 (4.8–18.0)* | 5.6 (1.3–11.6) | 7.0 (3.3–12.8)† |
Values are presented as the median and interquartile or mean ± SD
LC lanthanum carbonate group, CC calcium carbonate, cCa corrected calcium, P phosphorus, iPTH intact parathyroid hormone, iFGF23 intact fibroblast growth factor 23, LDL-C low density lipoprotein cholesterol, PS plaque score
*LC at 0 M versus LC at 18 M, p < 0.05; †CC at 0 M versus CC at 18 M, p < 0.05